Consequences of Recurrent Hyperkalemia on Cardiovascular Outcomes and Mortality
In patients with CKD, recurrent HK increased the risks of all-cause mortality, MACE+, and hospitalized arrhythmia compared with normokalemia, including in a subset of patients with HF.
Authors
- Abiy Agiro (ORCID: https://orcid.org/0000-0002-2369-8507)
- Elaine Louden (ORCID: https://orcid.org/0000-0003-1231-2223)
- Erin Cook (ORCID: https://orcid.org/0000-0001-9737-9130)
- George Bakris
- Manasvi Sundar (ORCID: https://orcid.org/0000-0001-5858-8685)
- Alexandra Greatsinger (ORCID: https://orcid.org/0000-0001-8576-8614)
- Fan Mu (ORCID: https://orcid.org/0000-0003-0252-0387)
- Ellen Colman
- Helen Guo (ORCID: https://orcid.org/0000-0002-5745-5677)
- Pooja Desai (ORCID: https://orcid.org/0000-0002-9546-0901)
Institutions
- Hypertension Institute (US)
- AstraZeneca (United States) (US)
- Analysis Group (United States) (US)
Publication Details
- Journal
- JACC Advances
- Published
- 2024-10-14
- DOI
- https://doi.org/10.1016/j.jacadv.2024.101331
- Citations
- 5
- Primary Topic
- Potassium and Related Disorders
- Type
- article
- Field-Weighted Citation Impact
- 2.09